TrialAlimentary pharmacology & therapeutics2017

Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial.

H Nakase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.